Development of tumor-targeted therapy using measles virus-displayed antibody library
Development of tumor-targeted therapy using measles virus-displayed antibody library
批准号:
22659227
负责人:
NAKAMURA Takafumi
金额:
$2.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
我们已经成功地开发了一种伪受体系统,它可以拯救和繁殖显示单链抗体片段(ScFv)的重定向病毒。因此,受体的选择不是靶向麻疹病毒的显著限制,使用单链抗体进行靶向可能使我们能够将病毒重定向到任何选择的细胞受体。在本研究中,我们试图利用肿瘤特异性单链抗体的鉴定技术来开发麻疹病毒展示的单链抗体文库(病毒体库)。以MOI为0的病毒体库感染人A549肺腺癌细胞或BxPC-3胰腺癌细胞。01~1,1h后用Opti-MEM(Invitgen)液冲洗细胞4次。感染后2~5d,通过反复冻融循环从GFP阳性感染细胞中获取增殖病毒。经过多次筛选,最终从GFP阳性的感染细胞中克隆出肿瘤靶向的麻疹病毒。用RT-PCR方法从病毒RNA基因组中扩增出单链抗体的编码区,并进行序列分析。然而,已鉴定的单链抗体并不具有肿瘤特异性抗体的功能。我们假设麻疹病毒显示的单链抗体文库的多样性不足以识别肿瘤特异性单链抗体。要解决这个问题,不是传统的结扎法,而是Gateway[0!采用基于技术的克隆方法(Invitgen)构建质粒文库。在埃德蒙斯顿麻疹病毒的全长cDNA克隆中,将不同类型的单链抗体插入受体失活的H基因的C末端。此外,利用表达T7 RNA聚合酶的辅助痘苗病毒从全长cDNA克隆中解救出显示麻疹单链抗体的传染性病毒。这些修饰极大地增加了麻疹病毒展示的单链抗体文库的多样性。
英文摘要
We have successfully developed a pseudoreceptor system which allows rescue and propagation of retargeted viruses displaying single chain antibody fragments(scFvs). Thus, receptor choice is not a significant limitation for targeting measles viruses and the use of single chain antibodies for targeting potentially allows us to redirect the virus against any chosen cellular receptor.In this study, we try to develop measles virus-displayed scFv library(virobody library) using the technology for identification of tumor-specific scFv. Human A549 lung, or BxPC-3 pancreatic carcinoma cells were infected with virobody library at an MOI of 0. 01 to 1, one hour later the cells were washed with Opti-MEM medium(Invitrogen) four times. 2 to 5 days after infection, propagated viruses were harvested by repeated freeze-thaw cycles from the GFP-positive infected cells. The biopanning was repeated several times, and finally the tumor-targeted measles virus was cloned from the GFP-positive infected cells. The cDNA encoding scFv from the viral RNA genome was amplified by RT-PCR for sequence analysis. However, the identified scFvs were not functional as a tumor-specific antibody. We have assumed that the diversity of measles virus-displayed scFv library is not sufficient enough to identify tumor-specific scFvs. To address this question, not traditional ligation method but Gateway[○! R] Technology-based cloning method(Invitrogen) was used for generation of plasmid library. Various kind of scFvs were incorporated into the C terminus of a receptor-blind H gene in a full-length cDNA clone of Edmonston measles virus. Furthermore, infectious scFv-displaying measles viruses were rescued from the full-length cDNA clones using helper vaccinia virus expressing T7 RNA polymerase. These modifications dramatically increased the diversity of measles virus-displayed scFv library.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/1472-6750-10-37
发表时间:
2010-05-06
期刊:
BMC biotechnology
影响因子:
3.5
作者:
[Katoh M, Kazuki Y, Kazuki K, Kajitani N, Takiguchi M, Nakayama Y, Nakamura T, Oshimura M]
通讯作者:
Oshimura M
マイクロRNAによって制御されるウイルスの開発とその応用
microRNA控制病毒的研制及其应用
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Sawada Y, Sugita K, Kabashima R, Hino R, Nakamura M, Koga C, Tokura Y, 高橋昭久, 中村貴史]
通讯作者:
中村貴史
MicroRNA Targeting of Oncolytic Viruses for cancer therapy
用于癌症治疗的溶瘤病毒的 MicroRNA 靶向
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Takafumi Nakamura.]
通讯作者:
Takafumi Nakamura.
Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy
高度减毒痘苗病毒作为癌症病毒治疗的潜在溶瘤剂
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Fusasaki T, Narita R, Hiura M, Abe S, Tabaru A, Hino R, Matsuyama A, Shimajiri S, Tokura Y, Sasaguri Y, Harada M, Nakamura T]
通讯作者:
Nakamura T
MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity
MicroRNA调控的溶瘤痘苗病毒不仅增强溶瘤活性还降低病毒致病性
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Nakamura M, Sugita K, Tokura Y, 大西武雄, Nakamura T]
通讯作者:
Nakamura T
共 17 条
Novel strategy of cancer virotherapy for radical cure of both primary and metastatic tumors
-
批准号:19H03515
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2019
-
负责人:NAKAMURA Takafumi
-
依托单位:
A novel oncolytic virotherapy for paclitaxel resistant ovarian cancer
-
批准号:17K19597
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.08万
-
财政年份:2017
-
负责人:NAKAMURA Takafumi
-
依托单位:
Tumor-targeted MAPK-dependent recombinant vaccinia virus for oncolytic virotherapy
-
批准号:15H04310
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2015
-
负责人:NAKAMURA Takafumi
-
依托单位:
Development of tumor-targeted therapy using lentivirus-displayed antibody library
-
批准号:24650629
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:NAKAMURA Takafumi
-
依托单位:
MicroRNA Targeting of Oncolytic Viruses for cancer therapy
-
批准号:22680065
-
项目类别:Grant-in-Aid for Young Scientists (A)
-
资助金额:$9.24万
-
财政年份:2010
-
负责人:NAKAMURA Takafumi
-
依托单位:
The concepts of rule and responsibility based on "New Humeanism"
-
批准号:21720004
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.41万
-
财政年份:2009
-
负责人:NAKAMURA Takafumi
-
依托单位:
Fundamental study in modern city at secondary education chance -Reproduction strategy of business layer where individual data was used-
-
批准号:20530788
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:NAKAMURA Takafumi
-
依托单位:
Development of the new treatment strategy for cancer using the transgenic mice that induced the epithelial tumors
-
批准号:19591927
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:NAKAMURA Takafumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TBK1通过磷酸化SLC7A11调控铁死亡抵抗促进鼻咽癌恶性进展的机制研究
-
批准号:2026JJ50595
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王维圆
-
依托单位:
瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
-
批准号:JCZRLH202600778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SDC1通过MMP11+CAF的细胞外基质重塑促进子宫颈癌化学免疫联合治疗耐药的机制研究
-
批准号:JCZRQNB202600504
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
多模态精准导航引导肝内胆管癌淋巴结清扫的动态示踪与机制探索
-
批准号:JCZRLH202600518
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
抗BNLF2b抗体联合circRNA构建鼻咽癌早期诊断模型及机制研究
-
批准号:JCZRLH202601732
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
乌梅丸调控CAFs分泌IL6+外泌体介导的SOX9信号通路抑制结直肠癌干性与转移的分子机制研究
-
批准号:JCZRQNB202600638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
-
批准号:JCZRLH202600400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
糖尿病驱动AGEs积聚进而激活RAGE/DIAPH1/RhoA信号通路促进子宫内膜癌转移的机制研究
-
批准号:JCZRLH202600969
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向子宫内膜癌的GCNT3 mRNA聚合物纳米递送系统的构建及转化研究
-
批准号:JCZRLH202601886
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
超声超分辨率成像评估甲状腺微小乳头状癌微波消融疗效的机制研究
-
批准号:JCZRLH202601676
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: